U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Childhood Acute Lymphoblastic Leukemia

MedGen UID:
75831
•Concept ID:
C0278519
•
Neoplastic Process
Synonyms: Recurrent Childhood Acute Lymphoid Leukemia; Recurrent Childhood ALL; Recurrent Childhood Precursor Lymphoblastic Leukemia; Recurrent Pediatric Acute Lymphoblastic Leukemia; Recurrent Pediatric Acute Lymphoid Leukemia; Recurrent Pediatric ALL; Relapsed Childhood Acute Lymphoblastic Leukemia; Relapsed Childhood ALL; Relapsed Pediatric Acute Lymphoblastic Leukemia; Relapsed Pediatric Acute Lymphoid Leukemia; Relapsed Pediatric ALL

Definition

The reemergence of acute lymphoblastic leukemia in childhood after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Childhood Acute Lymphoblastic Leukemia

Professional guidelines

PubMed

Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P
Haematologica 2000 Nov;85(11 Suppl):47-53. PMID: 11268324

Recent clinical studies

Etiology

Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction.
Koomagi R, Zintl F, Sauerbrey A, Volm M
Clin Cancer Res 2001 Nov;7(11):3381-4. PMID: 11705851
Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P
Haematologica 2000 Nov;85(11 Suppl):47-53. PMID: 11268324
Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H
Blood 1991 Sep 1;78(5):1166-72. PMID: 1878583
Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Pappo A, Dubowy R, Ravindranath Y, Alvarado C, Rao S, Whitehead VM, Vega R, Kamen B, Vietti T
J Natl Cancer Inst 1990 Oct 17;82(20):1641-2. doi: 10.1093/jnci/82.20.1641. PMID: 2145440

Diagnosis

Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction.
Koomagi R, Zintl F, Sauerbrey A, Volm M
Clin Cancer Res 2001 Nov;7(11):3381-4. PMID: 11705851
Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P
Haematologica 2000 Nov;85(11 Suppl):47-53. PMID: 11268324

Therapy

Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P
Haematologica 2000 Nov;85(11 Suppl):47-53. PMID: 11268324
Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia.
Crooks GM, Sato JK
J Pediatr Hematol Oncol 1995 Feb;17(1):34-8. doi: 10.1097/00043426-199502000-00006. PMID: 7743235
Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H
Blood 1991 Sep 1;78(5):1166-72. PMID: 1878583
Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Pappo A, Dubowy R, Ravindranath Y, Alvarado C, Rao S, Whitehead VM, Vega R, Kamen B, Vietti T
J Natl Cancer Inst 1990 Oct 17;82(20):1641-2. doi: 10.1093/jnci/82.20.1641. PMID: 2145440
Intermittent combined chemotherapy with doxorubicin in recurrent childhood acute lymphoblastic leukemia.
Ward Platt MP, Mott MG, Eden OB
Med Pediatr Oncol 1982;10(6):563-8. doi: 10.1002/mpo.2950100606. PMID: 6960230

Prognosis

Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction.
Koomagi R, Zintl F, Sauerbrey A, Volm M
Clin Cancer Res 2001 Nov;7(11):3381-4. PMID: 11705851
Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P
Haematologica 2000 Nov;85(11 Suppl):47-53. PMID: 11268324
Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H
Blood 1991 Sep 1;78(5):1166-72. PMID: 1878583

Clinical prediction guides

Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P
Haematologica 2000 Nov;85(11 Suppl):47-53. PMID: 11268324
Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.
Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H
Blood 1991 Sep 1;78(5):1166-72. PMID: 1878583

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...